Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00105742 · ClinicalTrials.gov registry record · Phase 2

Audiology Visits After Screening for Hearing Loss: An RCT

A Phase 2 study of Hard of Hearing, sponsored by US Department of Veterans Affairs.

Completed
Registry status
Phase 2
Development phase
1,400
Enrollment target
1
Study location

NCT00105742 is a Phase 2 study of Hard of Hearing that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 1,400 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00105742, a Phase 2 study of Hard of Hearing, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
Phase 2
Development phase
1,400 participants
Enrollment target
1
Study location

Study Summary

Hearing impairment is one of the most common disabilities in veterans. The decreased ability to communicate is troubling in itself, but the strong association of hearing loss with functional decline and depression adds further to the burden on the hearing-impaired. Although hearing amplification improves quality of life, hearing evaluations are offered infrequently to older patients. Only 25 percent of patients with aidable hearing loss receive treatment. Up to 30 percent of patients who receive hearing aids do not use them. We contend that an effective formal screening program should identify hearing-impaired patients who are motivated to seek evaluation and who derive benefit from treatment.

Conditions Studied

Interventions

  • PROCEDURE Diagnosis

Study Locations (1)

Washington

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA - Seattle

Trial Details

FieldValue
Enrollment Target 1,400 participants
Est. Completion 2005-06
Phase Phase 2

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00105742

The ClinicalTrials.gov registry entry for NCT00105742 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1,400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hard of Hearing appearing as the primary indexed condition, and to 1 intervention - of which Diagnosis is the first listed.

NCT00105742 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT00105742 about?

NCT00105742 is a clinical study titled "Audiology Visits After Screening for Hearing Loss: An RCT". Hearing impairment is one of the most common disabilities in veterans. The decreased ability to communicate is troubling in itself, but the strong association of hearing loss with functional decline and depression adds further to the burden on the hearing-impaired. Although hearing amplification imp...

What is the current status of trial NCT00105742?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,400 participants. Estimated completion is 2005-06.

What conditions does trial NCT00105742 study?

This clinical trial studies the following conditions: Hard of Hearing.

What interventions are being tested in trial NCT00105742?

The interventions under investigation include: Diagnosis (PROCEDURE).

Who is sponsoring clinical trial NCT00105742?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00105742 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.